IGF2BP2 and acute myeloid leukemia: Functional experiments further reveal that knockdown of IGF2BP2 in AML cells leads to reduced glutamine metabolism, impaired TCA cycle function, and decreased ATP production, while overexpression of IGF2BP2 enhances these metabolic processes.